Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 129-135 , 2009

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain

  • Khalid Mubarak Bindayna

      Affiliations

    • Department of Microbiology, Immunology and Infectious Diseases, Arabian Gulf University, Manama, Bahrain
    • Department of Pathology, Microbiology Section, Salmaniya Medical Complex, Bahrain
    • Corresponding Author InformationCorresponding author at: Department of Microbiology, Immunology and Infectious Diseases, College of Medicine and Medical Sciences, Arabian Gulf University, P.O. Box 226671, Manama, Bahrain. Tel.: +973 39462466; fax: +973 17271090.
    • ,
  • Abiola C. Senok

      Affiliations

    • Department of Clinical Sciences, College of Medicine, University of Sharjah, United Arab Emirates
    • ,
  • Afaf E. Jamsheer

      Affiliations

    • Department of Pathology, Microbiology Section, Salmaniya Medical Complex, Bahrain

Received 19 March 2009 ,Revised 21 April 2009 ,Accepted 28 April 2009.

References 

  1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–686
  2. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–951
  3. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315–317
  4. Empel J, Baraniak A, Literacka E, Mrowka A, Fiett J, Sadowy E, et al. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother. 2008;52:2449–2454
  5. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008;52:2818–2824
  6. Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother. 2005;56:451–454
  7. Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al Hashim G. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital. Med Prin Pract. 2005;14:325–331
  8. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO. The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother. 2008;20:445–451
  9. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Prin Pract. 2008;17:32–36
  10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 15th informational supplement (M100-S15). Wayne, PA, USA.
  11. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents. 2000;14:137–142
  12. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 1999;281:67–71
  13. Otman J, Cavassin ED, Perugini ME, Vidotto MC. An outbreak of extended-spectrum beta-lactamase-producing Klebsiella species in a neonatal intensive care unit in Brazil. Infect Control Hosp Epidemiol. 2002;23:8–9
  14. Pfaller MA, Jones RN, Doern GV. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the E-test method. Venezuelan Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis. 1999;35:153–158
  15. Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997–98). Braz J Infect Dis. 2000;4:245–254
  16. Bilal NE, Gedebou M. Clinical and community strains of Klebsiella pneumoniae: multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci. 2000;57:185–191
  17. Babay HA. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J. 2002;23:186–190
  18. El-Khizzi NA, Bakheshwain SM. Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J. 2006;27:37–40
  19. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med. 2005;25:239–242
  20. Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, et al. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother. 2007;60:140–144
  21. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–59
  22. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;62:284–288
  23. Shah AA, Hasan F, Ahmed S, Hameed A. Prevalence of extended-spectrum beta-lactamases in nosocomial and outpatients (ambulatory). Pak J Med Sci. 2003;19:187–191
  24. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, Amicosante G, et al. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol. 2006;44:1659–1664
  25. Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother. 2005;55:965–973
  26. Lartigue MF, Poirel L, Poyart C, Reglier-Poupet H, Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis. 2007;13:315–317
  27. Al Khaja KA, Sequeira RP, Damanhori AH, Ismaeel AY, Handu SS. Antimicrobial prescribing trends in primary care: implications for health policy in Bahrain. Pharmacoepidemiol Drug Saf. 2008;17:389–396
  28. Babypadmini S, Appalaraju B. Extended spectrum-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae—prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004;22:172–174
  29. Burgess DS, Hall RG, Lewis JS, Jorgensen JH, Patterson JE. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. Pharmacotherapy. 2003;23:1232–1237
  30. Ho PL, Wong RC, Yip KS, Loke SL, Leung MS, Mak GC, et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn Microbiol Infect Dis. 2007;59:439–445

PII: S1876-0341(09)00033-1

doi: 10.1016/j.jiph.2009.04.005

Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 129-135 , 2009

Article Tools

* Image Usage & Resolution